Implication for health policy/practice/research/medical education:
This review aims to present the evidence of benefit-risk assessment of cidofovir treatment for BK virus infection in kidney
transplant recipients. In this review, we discussed the efficacy and adverse side effects, which help physicians in the clinical
judgment for the use of cidofovir addition to a reduction of immunosuppressant. Moreover, this review also provides brief review
of current view in BK virus burden, clinical manifestation, diagnosis and other treatment methods which can be beneficial in
clinical practice and future research.
Please cite this paper as: Chesdachai S, Thongprayoon C, Bruminhent J, Cheungpasitporn W. Efficacy and adverse effects of
cidofovir for treatment of BK virus infection in kidney transplant recipients. J Nephropharmacol. 2018;7(1):10-17. DOI: 10.15171/